| Literature DB >> 17650450 |
Agustin Avilés, Claudia Castañeda, Natividad Neri, Sergio Cleto, M Jesús Nambo.
Abstract
Treatment of primary breast lymphoma (PBL) remains unsatisfactory. We assess a clinical study to evaluate efficacy and toxicity of a dose dense regimen (CEOP-14) and rituximab in 32 previously untreated female patients with PBL in early stage. There was no difference in complete response rate (87%), event free-survival (75%) and overall survival (63%) compared with historical patients.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17650450 DOI: 10.3324/haematol.10892
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941